BHVN
Price
$20.47
Change
-$3.21 (-13.56%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
2.1B
35 days until earnings call
OCUL
Price
$7.01
Change
-$0.33 (-4.50%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
1.11B
38 days until earnings call
Ad is loading...

BHVN vs OCUL

Header iconBHVN vs OCUL Comparison
Open Charts BHVN vs OCULBanner chart's image
Biohaven
Price$20.47
Change-$3.21 (-13.56%)
Volume$10.22K
Capitalization2.1B
Ocular Therapeutix
Price$7.01
Change-$0.33 (-4.50%)
Volume$31.49K
Capitalization1.11B
BHVN vs OCUL Comparison Chart
Loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHVN vs. OCUL commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a Hold and OCUL is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (BHVN: $20.55 vs. OCUL: $7.01)
Brand notoriety: BHVN and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 251% vs. OCUL: 135%
Market capitalization -- BHVN: $2.1B vs. OCUL: $1.11B
BHVN [@Biotechnology] is valued at $2.1B. OCUL’s [@Biotechnology] market capitalization is $1.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, both BHVN and OCUL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 4 TA indicator(s) are bullish while OCUL’s TA Score has 4 bullish TA indicator(s).

  • BHVN’s TA Score: 4 bullish, 5 bearish.
  • OCUL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BHVN is a better buy in the short-term than OCUL.

Price Growth

BHVN (@Biotechnology) experienced а -27.62% price change this week, while OCUL (@Biotechnology) price change was -9.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

BHVN is expected to report earnings on May 09, 2025.

OCUL is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHVN($2.1B) has a higher market cap than OCUL($1.12B). OCUL YTD gains are higher at: -17.916 vs. BHVN (-36.600). OCUL has higher annual earnings (EBITDA): -176.14M vs. BHVN (-877.26M). BHVN has more cash in the bank: 486M vs. OCUL (392M). BHVN has less debt than OCUL: BHVN (36.6M) vs OCUL (75.8M). OCUL has higher revenues than BHVN: OCUL (63.7M) vs BHVN (0).
BHVNOCULBHVN / OCUL
Capitalization2.1B1.12B188%
EBITDA-877.26M-176.14M498%
Gain YTD-36.600-17.916204%
P/E RatioN/AN/A-
Revenue063.7M-
Total Cash486M392M124%
Total Debt36.6M75.8M48%
FUNDAMENTALS RATINGS
BHVN vs OCUL: Fundamental Ratings
BHVN
OCUL
OUTLOOK RATING
1..100
5320
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
51
Fair valued
PROFIT vs RISK RATING
1..100
10091
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
9482
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
25n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OCUL's Valuation (51) in the Pharmaceuticals Other industry is in the same range as BHVN (59) in the Pharmaceuticals Major industry. This means that OCUL’s stock grew similarly to BHVN’s over the last 12 months.

OCUL's Profit vs Risk Rating (91) in the Pharmaceuticals Other industry is in the same range as BHVN (100) in the Pharmaceuticals Major industry. This means that OCUL’s stock grew similarly to BHVN’s over the last 12 months.

OCUL's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as BHVN (99) in the Pharmaceuticals Major industry. This means that OCUL’s stock grew similarly to BHVN’s over the last 12 months.

OCUL's Price Growth Rating (82) in the Pharmaceuticals Other industry is in the same range as BHVN (94) in the Pharmaceuticals Major industry. This means that OCUL’s stock grew similarly to BHVN’s over the last 12 months.

OCUL's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as BHVN (100) in the Pharmaceuticals Major industry. This means that OCUL’s stock grew similarly to BHVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHVNOCUL
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 11 days ago
75%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SFCWX65.440.84
+1.30%
American Funds SMALLCAP World F3
RGFTX9.710.08
+0.83%
Russell Inv Global Infrastructure M
FAGKX62.71N/A
N/A
Fidelity Growth Strategies K
FSEAX50.51N/A
N/A
Fidelity Emerging Asia
LDVIX22.95N/A
N/A
AXS FTSE Vntr Cptl RetTrckr I

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with OCUL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
+4.78%
OCUL - BHVN
44%
Loosely correlated
+12.23%
VCYT - BHVN
43%
Loosely correlated
+1.93%
XENE - BHVN
42%
Loosely correlated
+2.68%
KRYS - BHVN
41%
Loosely correlated
+3.68%
CGON - BHVN
40%
Loosely correlated
+0.86%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
-4.50%
EYPT - OCUL
54%
Loosely correlated
-7.26%
DNLI - OCUL
42%
Loosely correlated
-6.91%
BHVN - OCUL
42%
Loosely correlated
-13.22%
APGE - OCUL
42%
Loosely correlated
-7.61%
KRYS - OCUL
41%
Loosely correlated
-1.58%
More